Filing Details
- Accession Number:
- 0001179110-13-003984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-04 15:57:38
- Reporting Period:
- 2013-02-28
- Filing Date:
- 2013-03-04
- Accepted Time:
- 2013-03-04 15:57:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181185 | Per Olsen Wold | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94044 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-28 | 10,000 | $43.05 | 69,458 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Purchase prices reported for the transactions reported here range from $43.04 to $43.05. Full information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or its shareowners upon request.